NCT00376987View on ClinicalTrials.gov

Zinc Supplements in Lowering Cadmium Levels in Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

June 30, 2015

Conditions
Bladder CancerCervical CancerEsophageal CancerGastric CancerHead and Neck CancerKidney CancerLeukemiaLiver CancerLung CancerPancreatic CancerTobacco Use Disorder
Interventions
DIETARY_SUPPLEMENT

zinc oxide

Oral daily dietary supplement containing 80 mg Zinc oxide

Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00376987 - Zinc Supplements in Lowering Cadmium Levels in Smokers | Biotech Hunter | Biotech Hunter